Summary
- Current Price
- As of today, TRAX price is $36.24, up +11.85% on
- Current Price All-Time High
- TRAX price is currently -5.85% below its historical high of $38.49 set on
- Market Cap
- TRAX current market cap is $1B, with unknown 1-year change
- PE Ratio
- TRAX PE ratio is unknown
- Revenue
- TRAX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for TRAX is on
Profile
| Metric | Value |
|---|---|
| Full Name | First Tracks Biotherapeutics, Inc. |
| Ticker | NASDAQ: TRAX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | firsttracksbio.com |
| Employees | 104 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $36.24 | |
| Price, 1D Change | +11.85% | |
| $1B | ||
| - | ||
| - | ||
| 3.89 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| - | ||
| EPS, 1Y Change | - |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | TRAXV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| - | ||
| EPS Estimate | -$3.60 | |
| EPS Est. Change | - | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $36.24 | |
| Price Target | - | $42.00 |
| Price Tgt. Change | - | +15.89% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$3.05 | - | |
| - | N/A | - | |
| -$3.60 | N/A | -17.90% | |
| -$3.24 | N/A | -6.09% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $36.24 | |
| $19.32 | ||
| $18.71 | ||
| - | ||
| $19.96 | ||
| $2.73 | ||
| 3.89 | ||
| $2.90 | ||
| 82.87 | ||
| 284.12% | ||
| 165.44% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| - | ||
| - |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| - | ||
| - | ||
| - | ||
| -$181.10M | ||
| - | ||
| -$163.71M | ||
| - | ||
| -$178.70M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| 10.78 | ||
| - | ||
| - | ||
| - | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 4.91 | ||
| -19.28 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $391.60M | ||
| $123.08M | ||
| $441.89M | ||
| $389.93M | ||
| $50.30M | ||
| $36.18M | ||
| $16.04M | ||
| - | ||
| $3.79M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $181.10M | ||
| $181.10M | ||
| - | ||
| $28.76M | ||
| $2.40M | ||
| - | ||
| - |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$125.81M | ||
| $95.40M | ||
| $117.52M | ||
| $358.00K | ||
| -$126.16M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| No data | N/A | N/A |
Analyst sentiment
Institutional ownership
Screeners with TRAX
FAQ
What is the ticker symbol for First Tracks Biotherapeutics, Inc.?
The ticker symbol for First Tracks Biotherapeutics, Inc. is NASDAQ:TRAX
Does First Tracks Biotherapeutics, Inc. pay dividends?
No, First Tracks Biotherapeutics, Inc. does not pay dividends
What sector is First Tracks Biotherapeutics, Inc. in?
First Tracks Biotherapeutics, Inc. is in the Healthcare sector
What industry is First Tracks Biotherapeutics, Inc. in?
First Tracks Biotherapeutics, Inc. is in the Biotechnology industry
What country is First Tracks Biotherapeutics, Inc. based in?
First Tracks Biotherapeutics, Inc. is headquartered in United States
When did First Tracks Biotherapeutics, Inc. go public?
First Tracks Biotherapeutics, Inc. initial public offering (IPO) was on April 20, 2026
Is First Tracks Biotherapeutics, Inc. in the S&P 500?
No, First Tracks Biotherapeutics, Inc. is not included in the S&P 500 index
Is First Tracks Biotherapeutics, Inc. in the NASDAQ 100?
No, First Tracks Biotherapeutics, Inc. is not included in the NASDAQ 100 index
Is First Tracks Biotherapeutics, Inc. in the Dow Jones?
No, First Tracks Biotherapeutics, Inc. is not included in the Dow Jones index
When does First Tracks Biotherapeutics, Inc. report earnings?
The next expected earnings date for First Tracks Biotherapeutics, Inc. is August 7, 2026
Data Sources & References
- TRAX Official Website www.firsttracksbio.com
- TRAX Profile on Yahoo Finance finance.yahoo.com/quote/TRAX
- TRAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/trax